TP53 and cancer: Study on a p53 germline mutation database via a multivariate COX regression model suggested that mutation of R282 is related to a significantly earlier onset age of first tumor in the selected Li–Fraumeni syndrome patients than the nonsense (loss-of-function) mutations, while mutations on G245 residue showed later cancer-onset age.